Thyroid eye disease: What should optometrists know? (C-100503)

CPD
1
11 December 2020
Volume 21, Issue 4

This review aims to inform readers about thyroid eye disease.

Domains covered

Communication Clinical practice
Thyroid eye disease (TED) is an autoimmune condition in which the immune system becomes mistakenly activated against the patient’s own orbital tissues, causing inflammation and swelling. TED is relatively rare, affecting around 25 of every 100,000 people in the UK, so optometrists may not see many cases in their careers. However, TED is important because it is a very distressing condition that can threaten eyesight and alter facial appearance enough to cause permanent disfigurement if not treated. This review aims to inform readers about TED, and in particular to enable optometrists to recognise TED, to advise patients and recommend supportive treatment, to make appropriate onward referrals and to identify some of the treatments patients may receive after specialist referral.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

Speaker: Mandy Davidson BSc MCOptom

Adrian O’Dowd asks if the growing use of topography in community optometry will lead to wavefront analysis gaining traction as a complementary tool.

New research has found links between the severity of visual impairment and the risk of dementia. Kathy Oxtoby asks: how can optometrists play a greater role in supporting patients with these conditions?